Try our beta test site
1 study found for:    19815859 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Immunogenicity, Safety, and Tolerability of an MF59-Adjuvanted Versus Non-Adjuvanted Influenza Vaccines in Patients With Chronic Pulmonary Disease, Chronic Heart Disease, or Diabetes Mellitus
Conditions: H1N1 Influenza Virus;   Chronic Pulmonary Disease;   Chronic Heart Disease;   Diabetes Mellitus
Interventions: Biological: Focetria®;   Biological: Fluad®;   Biological: Begrivac®

Study has passed its completion date and status has not been verified in more than two years.